Zolgensma Gene Therapy Data Manipulation, GRF6019 Phase 2 Results in Mild to Moderate Alzheimer, Mind Moments Podcast
Neurology News Network for the week ending August 10, 2019.
Parkinson Disease Gene Therapy PR001 Granted Fast Track Designation, Telerehabilitation Similar to In-Clinic Rehab for Stroke, New Therapeutic Technologies In Epilepsy
Neurology News Network for the week ending July 13, 2019.
Solriamfetol Receives Schedule IV Designation for EDS in Narcolepsy, OSA, ABO-202 Gene Therapy Granted Fast Track Designation for Batten Disease, NfL Shows Multi-disease Usefulness
Neurology News Network for the week ending June 22, 2019.
Guidelines for Pediatric Migraine Clinical Trial Design Released, FDA Grants AMT-130 Fast Track Designation for Huntington Disease, ZX008 Receives RFL for Dravet Syndrome
Neurology News Network for the week of April 13, 2019.
2 Clarke Drive Cranbury, NJ 08512